Sodium/Hydrogen Exchanger 3 (NHE3) Inhibitors
- Name
- Sodium/Hydrogen Exchanger 3 (NHE3) Inhibitors
- Accession Number
- DBCAT005681
- Description
Agents inhibiting sodium/hydrogen exchanger 3 (NHE3).
- Drugs
Drug Drug Description Tenapanor An NHE3 inhibitor indicated for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic kidney disease, - Drugs & Drug Targets
Drug Target Type Tenapanor Sodium/hydrogen exchanger 3 target Tenapanor Cytochrome P450 3A4 enzyme Tenapanor Cytochrome P450 3A5 enzyme Tenapanor Solute carrier organic anion transporter family member 2B1 transporter